Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in research on ACE2 as a receptor for 2019-nCoV
Jie Wu, Wei Deng, Shumin Li, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 2, pp. 531-544
Open Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

Mutations in ace2 gene modulate cytokine levels and alter immune responses in Mycobacterium tuberculosis and SARS-CoV-2 co-infection: a Cameroonian cohort
Mary Ngongang Kameni, Eric Berenger Tchoupe, Séverin Donald Kamdem, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges
Abdurrahman Pharmacy Yusuf, Jianye Zhang, Jingquan Li, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 3, pp. 100280-100280
Open Access | Times Cited: 17
Update on Hypertension Research in 2021
Masaki Mogi, Tatsuya Maruhashi, Yukihito Higashi, et al.
Hypertension Research (2022) Vol. 45, Iss. 8, pp. 1276-1297
Open Access | Times Cited: 16
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
Abigael Chaouat, Ilija Brizić, Paola Kučan Brlić, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104935-104935
Open Access | Times Cited: 16
Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility
González Daniel, Ayala-Ramírez Paola, Nancy Gélvez, et al.
Infection Genetics and Evolution (2022) Vol. 104, pp. 105357-105357
Open Access | Times Cited: 16
Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
Saniya Mahendiratta, Seema Bansal, Phulen Sarma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111300-111300
Open Access | Times Cited: 23
A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2–Related Genes in Kidney Renal Clear Cell Carcinoma
Yongbiao Huang, Sheng Chen, Lingyan Xiao, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 9
Open Access | Times Cited: 15
A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?
Rashed Noor
Current Clinical Microbiology Reports (2021) Vol. 8, Iss. 3, pp. 186-193
Open Access | Times Cited: 20
Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review
Nitalia Naidoo, Jagidesa Moodley, Thajasvarie Naicker
Hypertension Research (2021) Vol. 44, Iss. 4, pp. 386-398
Open Access | Times Cited: 18
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
Hristo L. Svilenov, Julia Sacherl, A. Reiter, et al.
Antiviral Research (2021) Vol. 196, pp. 105197-105197
Open Access | Times Cited: 18
Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
Sandra González, Abu Bakar Siddik, Ruey‐Chyi Su
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 18
Genetic Association of Angiotensin-converting enzyme 2 ACE-2 (rs2285666) Polymorphism with the Susceptibility of COVID-19 Disease in Iraqi Patients
Risala H. Allami, Athraa H. Hassoon, Yasir M. Abdulateef, et al.
Tropical Journal of Natural Product Research (2023) Vol. 7, Iss. 2, pp. 2346-2351
Open Access | Times Cited: 7
Milk Peptides as Novel Multi‐Targeted Therapeutic Candidates for SARS-CoV2
H. Pradeep, Umme Najma, H.S. Aparna
The Protein Journal (2021) Vol. 40, Iss. 3, pp. 310-327
Open Access | Times Cited: 16
Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review
Kausar Sadia Fakhruddin, Lakshman P. Samaranayake, Borvornwut Buranawat, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0265531-e0265531
Open Access | Times Cited: 12
Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade
Mohaddeseh Bahmani, Rojin Chegini, Elham Ghanbari, et al.
World Journal of Virology (2022) Vol. 11, Iss. 3, pp. 113-128
Open Access | Times Cited: 11
The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection
Emilia Barreto-Durán, Artur Szczepański, Adrianna Gałuszka-Bulaga, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis
Iad Alhallak, Hakan Paydak, Jawahar L. Mehta
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101810-101810
Open Access | Times Cited: 6
A review on SARS-CoV-2 and stroke pathogenesis and outcome
Tamer Roushdy, Eman Hamid
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2021) Vol. 57, Iss. 1
Open Access | Times Cited: 13
Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
Amit Verma, Mirza Masroor Ali Beg, Deepti Bhatt, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 3131-3146
Open Access | Times Cited: 13
Anticipated pharmacological role of Aviptadil on COVID-19
Tuhin Mukherjee, Tapan Behl, Sanchay Sharma, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 6, pp. 8109-8125
Open Access | Times Cited: 13
SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review
Donatas Stakišaitis, Linas Kapočius, Angelija Valančiūtė, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 962-962
Open Access | Times Cited: 9
Vitamin D prescribing practices among clinical practitioners during the COVID‐19 pandemic
Edward B. Jude, Nikolaοs Tentolouris, Ashu Rastogi, et al.
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 9
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17
Jiayue He, Shuguang Liu, Qi Tan, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 9044-9044
Open Access | Times Cited: 9
Effect of B12 and folate deficiency in hypomethylation of Angiotensin I converting enzyme 2 gene and severity of disease among the acute respiratory distress syndrome patients
Reza Najafipour, Davood Mohammadi, Abdolmabood Momeni, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 5
Open Access | Times Cited: 5
Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells
Akira Nakazono, Yuji Nakamaru, Mahnaz Ramezanpour, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 12

Scroll to top